@NickBlasio@RevShark Not for a while fda approval unlocked a $40 mil line of credit. It was contingent on approval and they got it. No dilution for at least 6 months.
@RevShark Department of defense will be their first customer. They funded some of their clinical trials and wrote a letter to fda stating they want this product. No one has factored that in that’s a $100 mil order to have this readily available in every military hospital.
Investors in T-Rex 2X Inverse NVIDIA Daily Target ETF ($NVDQ) may have incurred substantial losses due to unsuitable broker advice that overlooked the unique risks of this leveraged exchange-traded fund (ETF). #NVDQ#TRex2xInverseNVDA
https://t.co/E74fDDm8Ik